Skip to content

Effect of percutaneous acupoint electrical stimulation on postoperative nausea and vomiting in high-risk patients undergoing gynecological laparoscopic surgery: a randomized controlled trial

Effect of percutaneous acupoint electrical stimulation on postoperative nausea and vomiting in high-risk patients undergoing gynecological laparoscopic surgery: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000363
Enrollment
Unknown
Registered
2024-09-03
Start date
2024-09-10
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adnexal disease

Interventions

Control group:The electrodes were attached at Zusanli points Sanyinjiao points Hegu points and Neiguan points on both sides and the acupoint stimulator was connected but no stimulation was performed.
Experimental group:The electrodes were attached at Zusanli points Sanyinjiao points Hegu points and Neiguan points on both sides and the acupoint stimulator was connected for stimulation.

Sponsors

The First People's Hospital of Jining
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Women aged 18-65 years old ASA grade I-II body mass index 18.5 to 28kg/m2 undergoing gynecological laparoscopic surgery under total intravenous anesthesia with a history of motion sickness or postoperative nausea and vomiting non-smoking Apfel score of 3-4 postoperative analgesic pump with opioids operation time 1-3 hours. The patient agrees and signs the informed consent form

Exclusion criteria

Exclusion criteria: Pregnant patients patients with skin damage at acupoint sites patients with heart disease or implantable electronic devices patients with psychiatric or neurological disorders patients with nausea and vomiting 48 hours before surgery patients with antiemetic or analgesic drugs or glucocorticoids 48 hours before surgery patients with acupuncture within one month patients with other clinical trials within one month

Design outcomes

Primary

MeasureTime frame
Incidence of nausea and vomiting 24 hours after surgery;

Secondary

MeasureTime frame
The highest score of nausea and vomiting 24 hours after surgery;Time of first anal exhaust;Time of first nausea or vomiting;Pain score within 24 hours after surgery;The number of cases in which antiemetic drugs were added within 24h after surgery;

Countries

China

Contacts

Public Contactgaoguangxia

The First People's Hospital of Jining

1518974558@qq.com18595201211

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026